{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T14:36:37Z","timestamp":1792938997027,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Reversible conduction failure (RCF) has been documented in acute motor axonal neuropathy (AMAN) and is considered a sign of nodopathy. Several reports of RCF in acute inflammatory demyelinating polyneuropathy (AIDP) have suggested that it could be a manifestation of nodopathy. We conducted this study to determine the frequency of RCF in AMAN and AIDP and to compare the clinical features between the two groups with or without RCF. RCF was observed in 38.9% and 18.5% patients in the AMAN and AIDP groups in our study, respectively. AIDP patients with anti-ganglioside antibodies represented 29.4% of the cohort. The clinical features of AIDP with RCF were more similar to those of AMAN with RCF than to those of typical AIDP. However, there were no significant differences in the frequency of anti-ganglioside antibody status between the groups. AIDP with RCF may be a manifestation of nodopathy. The current dichotomous electrodiagnostic criteria, classifying demyelinating and axonal neuropathy, are insufficient to define nodopathy. Further studies are required to revise the electrodiagnostic criteria for Guillain\u2013Barr\u00e9 syndrome.<\/jats:p>","DOI":"10.1038\/s41598-022-19547-0","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T07:11:40Z","timestamp":1667459500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reversible conduction failure in acute inflammatory demyelinating polyneuropathy"],"prefix":"10.1038","volume":"12","author":[{"given":"Sooyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"19547_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","volume":"86","author":"YA Rajabally","year":"2015","unstructured":"Rajabally, Y. A., Durand, M.-C., Mitchell, J., Orlikowski, D. & Nicolas, G. Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: Could a single study suffice?. J. Neurol. Neurosurg. Psychiatry 86, 115\u2013119 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"19547_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ana.410440210","volume":"44","author":"S Kuwabara","year":"1998","unstructured":"Kuwabara, S. et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barr\u00e9 syndrome. Ann. Neurol. 44, 202\u2013208 (1998).","journal-title":"Ann. Neurol."},{"key":"19547_CR3","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/01.wnl.0000335160.72184.7d","volume":"71","author":"K Kaida","year":"2008","unstructured":"Kaida, K. et al. GM1\/GalNAc-GD1a complex: A target for pure motor Guillain-Barr\u00e9 syndrome. Neurology 71, 1683\u20131690 (2008).","journal-title":"Neurology"},{"key":"19547_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jneuroim.2012.09.005","volume":"254","author":"G Ogawa","year":"2013","unstructured":"Ogawa, G. et al. An antibody to the GM1\/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barr\u00e9 syndrome with reversible conduction failure. J. Neuroimmunol. 254, 141\u2013145 (2013).","journal-title":"J. Neuroimmunol."},{"key":"19547_CR5","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1016\/j.clinph.2018.09.025","volume":"129","author":"A Uncini","year":"2018","unstructured":"Uncini, A. & Kuwabara, S. The electrodiagnosis of Guillain-Barr\u00e9 syndrome subtypes: Where do we stand?. Clin. Neurophysiol. 129, 2586\u20132593 (2018).","journal-title":"Clin. Neurophysiol."},{"key":"19547_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133520","volume":"10","author":"G Zhang","year":"2015","unstructured":"Zhang, G. et al. Subtypes and prognosis of Guillain-Barr\u00e9 syndrome in Southwest China. PLoS ONE 10, e0133520 (2015).","journal-title":"PLoS ONE"},{"key":"19547_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1586\/ern.09.43","volume":"9","author":"A Uncini","year":"2009","unstructured":"Uncini, A. & Yuki, N. Electrophysiologic and immunopathologic correlates in Guillain-Barr\u00e9 syndrome subtypes. Expert Rev. Neurotherapeut. 9, 869\u2013884 (2009).","journal-title":"Expert Rev. Neurotherapeut."},{"key":"19547_CR8","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1074\/mcp.M115.056036","volume":"15","author":"RH Ziganshin","year":"2016","unstructured":"Ziganshin, R. H. et al. The pathogenesis of the demyelinating form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and immunological profiling of physiological fluids. Mol. Cell. Proteom. 15, 2366\u20132378 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"19547_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11910-007-0022-6","volume":"7","author":"S Kuwabara","year":"2007","unstructured":"Kuwabara, S. Guillain-barre syndrome. Curr. Neurol. Neurosci. Rep. 7, 57\u201362s (2007).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"19547_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.expneurol.2011.11.039","volume":"233","author":"K Susuki","year":"2012","unstructured":"Susuki, K. et al. Dysfunction of nodes of Ranvier: A mechanism for anti-ganglioside antibody-mediated neuropathies. Exp. Neurol. 233, 534\u2013542 (2012).","journal-title":"Exp. Neurol."},{"key":"19547_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko, C. et al. Acute motor axonal neuropathy: An antibody-mediated attack on axolemma. Ann. Neurol. 40, 635\u2013644 (1996).","journal-title":"Ann. Neurol."},{"key":"19547_CR12","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","volume":"27","author":"K Susuki","year":"2007","unstructured":"Susuki, K. et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 27, 3956\u20133967 (2007).","journal-title":"J. Neurosci."},{"key":"19547_CR13","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/brain\/awq119","volume":"133","author":"R McGonigal","year":"2010","unstructured":"McGonigal, R. et al. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 133, 1944\u20131960 (2010).","journal-title":"Brain"},{"key":"19547_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/mus.27115","volume":"63","author":"SJ Oh","year":"2021","unstructured":"Oh, S. J. Nodal conduction block: A unifying concept. Muscle Nerve 63, 178\u2013180 (2021).","journal-title":"Muscle Nerve"},{"key":"19547_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fneur.2019.00714","volume":"10","author":"J Tian","year":"2019","unstructured":"Tian, J. et al. Electrophysiological subtypes and prognostic factors of Guillain-Barre Syndrome in northern China. Front. Neurol. 10, 714 (2019).","journal-title":"Front. Neurol."},{"key":"19547_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jocn.2020.04.059","volume":"80","author":"JC L\u00f3pez-Hern\u00e1ndez","year":"2020","unstructured":"L\u00f3pez-Hern\u00e1ndez, J. C. et al. Electrophysiological subtypes and associated prognosis factors of Mexican adults diagnosed with Guillain-Barr\u00e9 syndrome, a single center experience. J. Clin. Neurosci. 80, 292\u2013297 (2020).","journal-title":"J. Clin. Neurosci."},{"key":"19547_CR17","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","volume":"124","author":"A Uncini","year":"2013","unstructured":"Uncini, A., Susuki, K. & Yuki, N. Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin. Neurophysiol. 124, 1928\u20131934 (2013).","journal-title":"Clin. Neurophysiol."},{"key":"19547_CR18","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","volume":"86","author":"A Uncini","year":"2015","unstructured":"Uncini, A. & Kuwabara, S. Nodopathies of the peripheral nerve: An emerging concept. J. Neurol. Neurosurg. Psychiatry 86, 1186\u20131195 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"19547_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"R Hadden","year":"1998","unstructured":"Hadden, R. et al. Electrophysiological classification of Guillain-Barr\u00e9 syndrome: Clinical associations and outcome. Ann. Neurol. 44, 780\u2013788 (1998).","journal-title":"Ann. Neurol."},{"key":"19547_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.clinph.2017.03.048","volume":"128","author":"A Uncini","year":"2017","unstructured":"Uncini, A., Ippoliti, L., Shahrizaila, N., Sekiguchi, Y. & Kuwabara, S. Optimizing the electrodiagnostic accuracy in Guillain-Barr\u00e9 syndrome subtypes: Criteria sets and sparse linear discriminant analysis. Clin. Neurophysiol. 128, 1176\u20131183 (2017).","journal-title":"Clin. Neurophysiol."},{"key":"19547_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14253\/acn.2020.22.1.13","volume":"22","author":"B-A Yoon","year":"2020","unstructured":"Yoon, B-A., Bae, J. S. & Kim, J. K. Electrognostic findings of Guillain-Barr\u00e9 syndrome. Ann. Clin. Neurophysiol. 22, 13\u201318 (2020).","journal-title":"Ann. Clin. Neurophysiol."},{"key":"19547_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","volume":"48","author":"K Ogawara","year":"2000","unstructured":"Ogawara, K. et al. Axonal Guillain-Barr\u00e9 syndrome: Relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann. Neurol. 48, 624\u2013631 (2000).","journal-title":"Ann. Neurol."},{"key":"19547_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fneur.2021.760889","volume":"12","author":"J Zhu","year":"2021","unstructured":"Zhu, J. et al. Anti-ganglioside antibodies in Guillain-Barre syndrome: A novel immunoblotting-panel assay. Front. Neurol. 12, 5 (2021).","journal-title":"Front. Neurol."},{"key":"19547_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/glycob\/cwp027","volume":"19","author":"K Kaida","year":"2009","unstructured":"Kaida, K., Ariga, T. & Yu, R. K. Antiganglioside antibodies and their pathophysiological effects on Guillain-Barr\u00e9 syndrome and related disorders\u2014a review. Glycobiology 19, 676\u2013692 (2009).","journal-title":"Glycobiology"},{"key":"19547_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2183\/pjab.88.299","volume":"88","author":"N Yuki","year":"2012","unstructured":"Yuki, N. Guillain-Barr\u00e9 syndrome and anti-ganglioside antibodies: A clinician-scientist\u2019s journey. Preceed. Jpn. Acad. Ser. B 88, 299\u2013326 (2012).","journal-title":"Preceed. Jpn. Acad. Ser. B"},{"key":"19547_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/01.WNL.0000133205.05169.04","volume":"63","author":"S Kuwabara","year":"2004","unstructured":"Kuwabara, S. et al. Does Campylobacter jejuni infection elicit \u201cdemyelinating\u201d Guillain-Barr\u00e9 syndrome?. Neurology 63, 529\u2013533 (2004).","journal-title":"Neurology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19547-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19547-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19547-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T07:15:19Z","timestamp":1667459719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19547-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19547"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19547-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742395584.793597540","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18562"}}